Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Back To Doctor Search

Douglas W. Laske, MD

Douglas W. Laske

  • Adjunct Professor, Neurological Surgery, Lewis Katz School of Medicine at Temple University

Specialties

Neurosurgery

Loading ...
About Me
Publications
About Me
Education
  • MD, Columbia University College of Physicians & Surgeons, New York, NY
Training
  • Fellowship, Neuro-Oncology, National Institutes of Health, Rockville, MD
  • Residency, Neurological Surgery, Virginia Commonwealth University Health System, Richmond, VA
Memberships
  • Congress of Neurological Surgeons
  • Fellow, American Association of Neurological Surgeons
  • Pennsylvania Neurosurgical Society
  • Philadelphia County Medical Society
  • Pennsylvania Medical Society
  • Society for Neuro-Oncology
Awards and Honors
  • Fellowship, Brain Tumor Surgery and Treatment, National Institutes of Health
  • Chief, Division of Neurosurgery, Abington Hospital
  • Top Docs, Philadelphia Magazine, 2010-2014
  • America's Top Doctors, Castle Connolly, 2010-2014
  • America's Top Doctors for Cancer, Castle Connolly, 2009-2013
  • Best Doctors in America®, Neurological Surgery, 2015-2016, 2017-2018, 2019-2020
Offices

Office Locations

Neurosurgical Associates of Abington

2510 Maryland Rd.

Suite 185

Willow Grove, PA 19090

Phone: 215-657-5886

Publications
Publications

Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients.; Neurosurgery. 2005 Jun.

Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer. Cole, M., Parajuli, S., Laske, D., Goldstein, L., Morrison, T., Mukherjee, A.,Tumelty, K.,Tetzlaff, E.,von Mehren, M.,Inniss, S.; Am J Case Rep. 2014 Jul 22.

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. Weaver, M., Laske, D. W.; J Neurooncol. 2003 Oct.

Ratings & Reviews

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient Comments

Loading ...